Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Clinical trial NCT07297979 · RECRUITING
Trial details
- NCT number
- NCT07297979
- Sponsor
- Amgen
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-08
- Primary completion
- 2030-05-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.